Evelyn Partners Investment Management LLP Has $10.49 Million Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Evelyn Partners Investment Management LLP trimmed its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 37.9% during the first quarter, HoldingsChannel reports. The fund owned 147,330 shares of the company’s stock after selling 89,949 shares during the quarter. Evelyn Partners Investment Management LLP’s holdings in GE HealthCare Technologies were worth $10,487,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Banque Cantonale Vaudoise lifted its holdings in GE HealthCare Technologies by 16,539.1% during the 1st quarter. Banque Cantonale Vaudoise now owns 25,957 shares of the company’s stock worth $1,849,000 after buying an additional 25,801 shares during the period. Allstate Corp increased its stake in shares of GE HealthCare Technologies by 100.3% in the fourth quarter. Allstate Corp now owns 32,688 shares of the company’s stock valued at $2,681,000 after buying an additional 16,365 shares during the period. Perpetual Ltd acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at about $37,656,000. Herbst Group LLC acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at about $2,276,000. Finally, Auto Owners Insurance Co raised its position in shares of GE HealthCare Technologies by 9,525.4% during the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock worth $278,725,000 after acquiring an additional 33,629,559 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Up 0.9%

GE HealthCare Technologies stock opened at $61.12 on Tuesday. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77. The firm’s fifty day moving average is $63.63 and its 200 day moving average is $70.96. The company has a market capitalization of $27.80 billion, a PE ratio of 14.62, a PEG ratio of 1.65 and a beta of 0.72.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. During the same quarter in the previous year, the business posted $1.01 earnings per share. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.35%.

Insider Transactions at GE HealthCare Technologies

In other news, Director Rodney F. Hochman acquired 1,618 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The stock was purchased at an average price of $62.03 per share, for a total transaction of $100,364.54. Following the completion of the acquisition, the director directly owned 1,618 shares in the company, valued at $100,364.54. The trade was a ∞ increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Kevin Lobo bought 10,000 shares of the stock in a transaction dated Friday, May 22nd. The shares were purchased at an average cost of $64.18 per share, for a total transaction of $641,800.00. Following the completion of the transaction, the director directly owned 14,363 shares of the company’s stock, valued at $921,817.34. This trade represents a 229.20% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last ninety days, insiders have acquired 21,847 shares of company stock valued at $1,361,355. Company insiders own 0.36% of the company’s stock.

Analyst Ratings Changes

GEHC has been the topic of a number of recent analyst reports. BTIG Research reaffirmed a “buy” rating and issued a $75.00 price objective on shares of GE HealthCare Technologies in a research note on Monday, July 13th. Rothschild & Co Redburn lowered their price target on shares of GE HealthCare Technologies from $110.00 to $98.00 in a report on Thursday, April 30th. Weiss Ratings downgraded shares of GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 15th. HSBC dropped their price target on shares of GE HealthCare Technologies from $100.00 to $90.00 in a research report on Thursday, April 30th. Finally, Zacks Research cut shares of GE HealthCare Technologies from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 21st. Ten equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Hold” and an average target price of $76.41.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.